For meetings and deliveries:
12 Veterans Square
1st Floor Left
Media, PA 19063 U.S.A.
P.O. Box 209
Swarthmore, PA 19081-0209 U.S.A.
Phone: (610) 892-9942
Twitter: @TechLaw_Elman and @ElmanTechNews
eFax: (925) 226-4995
- Selected Developments in Biotechnology Law and the Biotechnology Industry
- Informed Consent and Ethical Review in Chinese Human Experimentation: Reflections on the “Golden Rice Event”
- Q&A Session with Dr. Andrew W. Torrance of the University of Kansas School of Law: On the Question: Is Copyright the Way to Gain Intellectual Property Protection for DNA Sequences?
On May 30, 2012, the Court of Appeals for the Federal Circuit (“CAFC”) put further gloss on the term “common sense” as used by the Supreme Court in the 2007 case of KSR v. Teleflex.
This new case (Mintz v. Dietz & Watson) involved a patent on casings for hot dogs with a woven mesh pattern. The CAFC opinion criticized the district court for finding the patent claim to have been obvious, under the “common sense” rubric. The CAFC explained that “common sense” is a “shorthand label for knowledge so basic that it certainly lies within the skill set of an ordinary artisan.”
- “CyberWar Threat” airs Oct. 14, 2015 on PBS Nova
- Don’t Let a Defective Provisional Sink Your Patent
- Gerry Elman and Josh Waterston to speak at Chester County Bar Association meeting
- Elman Technology Law sponsoring Philly Tech Week event in Media, PA
- Oct. 20, 2014 – Meet Steve Zeman and get tips about European Patent Office practice
- How to Successfully Challenge (Or Defend) a Patent before the USPTO Patent Trial and Appeal Board
- Gilead Has Successfully Obtained a Declaration of Invalidity of a Patent that It Reasonably Expected Would Be Asserted Against It
- Acronyms and the issue of descriptiveness under the Canadian Trademarks Act
- Federal Circuit Rules That ITC Does Not Have Jurisdiction Over Digital Imports
- PTAB May Allow a Petitioner to Correct An Improper IPR Reply Brief
- Patent Infringement Safe Harbor and Importation Redefined: Ruling Incentivizes Generic Pharmaceutical Offshore Product Testing